Global Laser Endomicroscopy Market, By Type (Confocal Laser Endomicroscopy (CLE), Volumetric Laser Endomicroscopy (VLE)), CLE Product Type (Probe-Based, Endoscopy-Based), CLE Application (Pancreatic, Luminal, Biliary, Others), End-Users (Diagnostic Clinics, Hospitals, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Laser Endomicroscopy Market
The laser endomicroscopy market is expected to witness market growth at a rate of XX% in the forecast period of 2021 to 2028. Data Bridge Market Research report on laser endomicroscopy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of laser endomicroscopy market.
Laser endomicroscopy refers to an innovative diagnostic/imaging technology that is used in various endoscopic procedures. This laser endomicroscopy is characterized in two categories including confocal laser endomicroscopy, and volumetric laser endomicroscopy. Confocal laser endomicroscopy is defined as a technique used in the detection of gastrointestinal and pancreatobiliary diseases especially during an endoscopic procedure.
The increase in prevalence of gastric disease across the globe acts as one of the major factors driving the growth of laser endomicroscopy market. The high adoption rate of confocal laser endomicroscopy system in various gastrointestinal diagnosis and treatment owning to the painless and less time-consuming ability of the laser accelerate the market growth. The better performance of lasers over traditional material processing techniques and preference for laser-based material processing over traditional approaches further influence the market. Additionally, surge in healthcare expenditure, favorable reimbursement procedures and shift toward production of nano devices and micro devices positively affect the laser endomicroscopy market. Furthermore, advancements in the laser endomicroscopy extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the devices and technology is expected to obstruct the market growth. Lack of trained staff and inadequate efficacy is projected to challenge the laser endomicroscopy market in the forecast period of 2021 to 2028.
This laser endomicroscopy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on laser endomicroscopy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Laser Endomicroscopy Market Scope and Market Size
The laser endomicroscopy market is segmented on the basis of type, CLE product type, CLE application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the laser endomicroscopy market is segmented into confocal laser endomicroscopy (CLE) and volumetric laser endomicroscopy (VLE).
- On the basis of CLE product type, the laser endomicroscopy market is segmented into probe-based, and endoscopy-based.
- On the basis of CLE application, the laser endomicroscopy market is segmented into pancreatic, luminal, biliary and others.
- On the basis of end-users, the laser endomicroscopy market is segmented into diagnostic clinics, hospitals, and ambulatory surgical centers.
Laser Endomicroscopy Market Country Level Analysis
The laser endomicroscopy market is segmented on the basis of type, CLE product type, CLE application and end-users.
The countries covered in the laser endomicroscopy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the laser endomicroscopy market because of the adaptation of minimally invasive procedure or confocal laser endomicroscopy system within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the growing manufacturing and electronics sectors in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The laser endomicroscopy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for laser endomicroscopy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the laser endomicroscopy market. The data is available for historic period 2010-2019.
Competitive Landscape and Laser Endomicroscopy Market Share Analysis
The laser endomicroscopy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to laser endomicroscopy market.
The major players covered in the laser endomicroscopy market report are Cook, Mauna Kea Technologies, PENTAX Medical, Carl Zeiss AG, NinePoint Medical, Inc. and Zygo Corporation., OLYMPUS CORPORATION, Danaher, KEYENCE CORPORATION, Carl Zeiss AG, Caliber Imaging & Diagnostics, Lasertec Corporation, Thorlabs, Inc., Oxford Instruments, NanoFocus AG, Intelligent Imaging Innovations, Thermo Fisher Scientific Inc., Bruker, Aurox Ltd, Scientifica, A Judges Scientific plc company, NanoScope Systems Co., Ltd., ISS, Inc., and Nikon Instruments Inc., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL LASER ENDOMICROSCOPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL LASER ENDOMICROSCOPY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES DATA VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL LASER ENDOMICROSCOPY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL LASER ENDOMICROSCOPY MARKET, BY TYPE
16.1 OVERVIEW
16.2 CONFOCAL LASER ENDOMICROSCOPY (CLE)
16.2.1 BY TYPE
16.2.1.1. POINT SCANNING ENDOMICROSCOPES
16.2.1.2. FIBRE BUNDLE ENDOMICROSCOPES
16.2.2 BY PRODUCT
16.2.2.1. PROBE-BASED
16.2.2.2. ENDOSCOPY-BASED
16.2.3 BY EMISSION FILTER
16.2.3.1. GREEN FILTER
16.2.3.2. RED FILTER
16.2.3.3. NEUTRAL FILTERS
16.2.4 OTHERS
16.3 VOLUMETRIC LASER ENDOMICROSCOPY (VLE)
17 GLOBAL LASER ENDOMICROSCOPY MARKET, BY PRODUCT TYPE
17.1 OVERVIEW
17.2 SYSTEMS
17.2.1 BY TYPE
17.2.1.1. SYSTEMS WITH OPTICAL FIBRES
17.2.1.2. SYSTEMS WITH VIDEO PROCESSOR
17.2.2 BY MODALITY
17.2.2.1. HANDHELD
17.2.2.2. WORKBENCH
17.2.3 OTHERS
17.3 DYES
17.3.1 FLOURESCEIN
17.3.2 ACRIFLAVINE HYDROCHLORIDE
17.3.3 CRESYL VIOLET
17.3.4 OTHERS
17.4 SOFTWARE
18 GLOBAL LASER ENDOMICROSCOPY MARKET, BY LASER TECHNOLOGY
18.1 OVERVIEW
18.2 CONFOCAL LASER
18.3 FLUORESCENCE LASER
19 GLOBAL LASER ENDOMICROSCOPY MARKET, BY APPLICATION
19.1 OVERVIEW
19.2 CLINICAL APPLICATIONS
19.2.1 APPLICATIONS IN GASTROENTEROLOGY
19.2.1.1. COLORECTAL CANCER
19.2.1.1.1. PROBE-BASED
19.2.1.1.2. ENDOSCOPY-BASED
19.2.1.2. INFLAMMATORY BOWEL DISEASES
19.2.1.2.1. PROBE-BASED
19.2.1.2.2. ENDOSCOPY-BASED
19.2.1.3. BARRETT’S ESOPHAGUS
19.2.1.3.1. PROBE-BASED
19.2.1.3.2. ENDOSCOPY-BASED
19.2.1.4. GASTRIC CANCER
19.2.1.4.1. PROBE-BASED
19.2.1.4.2. ENDOSCOPY-BASED
19.2.1.5. COELIAC DISEASE
19.2.1.5.1. PROBE-BASED
19.2.1.5.2. ENDOSCOPY-BASED
19.2.2 APPLICATIONS IN HEPATOLOGY
19.2.2.1. PROBE-BASED
19.2.2.2. ENDOSCOPY-BASED
19.2.3 APPLICATIONS IN OVARIAN CANCER
19.2.3.1. PROBE-BASED
19.2.3.2. ENDOSCOPY-BASED
19.2.4 APPLICATIONS IN PULMONOLOGY
19.2.4.1. PROBE-BASED
19.2.4.2. ENDOSCOPY-BASED
19.2.5 APPLICATIONS IN UROLOGY
19.2.5.1. PROBE-BASED
19.2.5.2. ENDOSCOPY-BASED
19.2.6 OTHERS
19.3 PRECLINICAL APPLICATIONS
20 GLOBAL LASER ENDOMICROSCOPY MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 PUBLIC
20.2.2 PRIVATE
20.3 DIAGNOSTIC CLINICS
20.4 AMBULATORY SURGICAL CENTERS
20.5 ACADEMIC AND RESEARCH CENTRE
20.6 OTHERS
21 GLOBAL LASER ENDOMICROSCOPY MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 THIRD PARTY DISTRIBUTORS
21.4 OTHERS
22 GLOBAL LASER ENDOMICROSCOPY MARKET, BY GEOGRAPHY
GLOBAL LASER ENDOMICROSCOPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
22.1 NORTH AMERICA
22.1.1 U.S.
22.1.2 CANADA
22.1.3 MEXICO
22.2 EUROPE
22.2.1 GERMANY
22.2.2 U.K.
22.2.3 ITALY
22.2.4 FRANCE
22.2.5 SPAIN
22.2.6 RUSSIA
22.2.7 SWITZERLAND
22.2.8 TURKEY
22.2.9 BELGIUM
22.2.10 NETHERLANDS
22.2.11 LUXEMBURG
22.2.12 REST OF EUROPE
22.3 ASIA-PACIFIC
22.3.1 JAPAN
22.3.2 CHINA
22.3.3 SOUTH KOREA
22.3.4 INDIA
22.3.5 SINGAPORE
22.3.6 THAILAND
22.3.7 INDONESIA
22.3.8 MALAYSIA
22.3.9 PHILIPPINES
22.3.10 AUSTRALIA & NEW ZEALAND
22.3.11 REST OF ASIA-PACIFIC
22.4 SOUTH AMERICA
22.4.1 BRAZIL
22.4.2 ARGENTINA
22.4.3 REST OF SOUTH AMERICA
22.5 MIDDLE EAST AND AFRICA
22.5.1 SOUTH AFRICA
22.5.2 EGYPT
22.5.3 SAUDI ARABIA
22.5.4 UNITED ARAB EMIRATES
22.5.5 ISRAEL
22.5.6 REST OF MIDDLE EAST AND AFRICA
23 GLOBAL LASER ENDOMICROSCOPY MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: GLOBAL
23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.3 COMPANY SHARE ANALYSIS: EUROPE
23.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
23.5 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
23.6 MERGERS & ACQUISITIONS
23.7 NEW PRODUCT DEVELOPMENT & APPROVALS
23.8 EXPANSIONS
23.9 REGULATORY CHANGES
23.1 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 GLOBAL LASER ENDOMICROSCOPY MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL LASER ENDOMICROSCOPY MARKET, COMPANY PROFILE
25.1 SYNECTICS MEDICAL LIMITED
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 IMEDEX S.R.O.
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 COOK
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 ZEISS GROUP
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 MAUNA KEA TECHNOLOGIES
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 BVI
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 PENTAX MEDICAL (A SUBSIDIARY OF HOYA CORPORATION)
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 OPTISCAN IMAGING LTD
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 OLYMPUS CORPORATION
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 MERIT MEDICAL SYSTEMS INC.
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 NINEPOINT MEDICAL, INC.
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
